| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.785 | 0.002 | 0.785 | Plasminogen activator inhibitor antagonist | 0.054 0.028 DBMET01828 | ||
| 0.782 | 0.018 | 0.807 | Antiinflammatory | 0.807 0.014 DBMET01828 | DBMET01828 | |
| 0.734 | 0.004 | 0.734 | Immunosuppressant | 0.72 0.005 DBMET01828 | ||
| 0.698 | 0.005 | 0.698 | Platelet antagonist | 0.347 0.039 DBMET01828 | ||
| 0.65 | 0.01 | 0.65 | Vasodilator, peripheral | 0.62 0.014 DBMET01828 | ||
| 0.603 | 0.004 | 0.603 | Anesthetic general | 0.357 0.023 DBMET01828 | ||
| 0.596 | 0.019 | 0.634 | Cholesterol antagonist | 0.634 0.014 DBMET01828 | DBMET01828 | |
| 0.558 | 0.013 | 0.558 | Caspase 3 stimulant | 0.368 0.054 DBMET01828 | ||
| 0.553 | 0.017 | 0.553 | Spasmolytic | 0.444 0.032 DBMET01828 | ||
| 0.533 | 0.005 | 0.533 | Interleukin 2 agonist | 0.481 0.01 DBMET01828 | ||
| 0.551 | 0.028 | 0.551 | Antibacterial | 0.479 0.047 DBMET01828 | ||
| 0.476 | 0.007 | 0.476 | Interferon gamma antagonist | 0.376 0.012 DBMET01828 | ||
| 0.497 | 0.029 | 0.497 | Antithrombotic | 0.478 0.032 DBMET01828 | ||
| 0.519 | 0.053 | 0.519 | Caspase 9 stimulant | 0.47 0.073 DBMET01828 | ||
| 0.497 | 0.045 | 0.497 | Transcription factor NF kappa B inhibitor | 0.374 0.07 DBMET01828 | ||
| 0.467 | 0.015 | 0.467 | Hypolipemic | 0.342 0.037 DBMET01828 | ||
| 0.517 | 0.069 | 0.517 | Apoptosis agonist | 0.425 0.102 DBMET01828 | ||
| 0.43 | 0.004 | 0.43 | Vanilloid agonist | 0.094 0.041 DBMET01828 | ||
| 0.449 | 0.031 | 0.449 | Immunomodulator | 0.401 0.043 DBMET01828 | ||
| 0.423 | 0.008 | 0.423 | Alpha-N-acetylglucosaminidase inhibitor | 0.415 0.008 DBMET01828 | ||
| 0.43 | 0.015 | 0.43 | Interleukin agonist | 0.365 0.025 DBMET01828 | ||
| 0.425 | 0.011 | 0.425 | Sodium/bile acid cotransporter inhibitor | 0.361 0.033 DBMET01828 | ||
| 0.434 | 0.022 | 0.488 | Nitric oxide antagonist | 0.488 0.017 DBMET01828 | DBMET01828 | |
| 0.418 | 0.01 | 0.418 | Thrombolytic | 0.152 0.08 DBMET01828 | ||
| 0.409 | 0.004 | 0.409 | Cholesterol synthesis inhibitor | 0.377 0.005 DBMET01828 | ||
| 0.431 | 0.027 | 0.431 | Vasodilator, coronary | 0.324 0.069 DBMET01828 | ||
| 0.408 | 0.006 | 0.408 | Antipruritic | 0.294 0.015 DBMET01828 | ||
| 0.411 | 0.021 | 0.411 | Calcium channel activator | 0.352 0.049 DBMET01828 | ||
| 0.376 | 0.014 | 0.376 | Melanin inhibitor | 0.261 0.027 DBMET01828 | ||
| 0.433 | 0.074 | 0.601 | Cyclophilin D inhibitor | 0.601 0.027 DBMET01828 | DBMET01828 | |
| 0.38 | 0.024 | 0.38 | Transcription factor STAT inhibitor | 0.236 0.097 DBMET01828 | ||
| 0.419 | 0.076 | 0.419 | Analgesic | |||
| 0.358 | 0.018 | 0.358 | Platelet adhesion inhibitor | 0.267 0.044 DBMET01828 | ||
| 0.361 | 0.023 | 0.369 | RNA-directed DNA polymerase inhibitor | 0.369 0.022 DBMET01828 | DBMET01828 | |
| 0.34 | 0.004 | 0.341 | ATPase inhibitor | 0.341 0.004 DBMET01828 | DBMET01828 | |
| 0.339 | 0.006 | 0.386 | Expectorant | 0.386 0.005 DBMET01828 | DBMET01828 | |
| 0.36 | 0.031 | 0.36 | Vasodilator | 0.29 0.051 DBMET01828 | ||
| 0.334 | 0.01 | 0.334 | Anesthetic local | 0.149 0.049 DBMET01828 | ||
| 0.374 | 0.057 | 0.374 | Immunostimulant | 0.339 0.067 DBMET01828 | ||
| 0.322 | 0.005 | 0.322 | Cyclooxygenase 3 inhibitor | 0.169 0.034 DBMET01828 | ||
| 0.328 | 0.012 | 0.328 | Neurotrophic factor enhancer | 0.3 0.018 DBMET01828 | ||
| 0.33 | 0.017 | 0.337 | Gastrin inhibitor | 0.337 0.014 DBMET01828 | DBMET01828 | |
| 0.34 | 0.028 | 0.345 | 5 Hydroxytryptamine uptake stimulant | 0.345 0.027 DBMET01828 | DBMET01828 | |
| 0.307 | 0.005 | 0.307 | T cell inhibitor | 0.21 0.007 DBMET01828 | ||
| 0.303 | 0.004 | 0.303 | Photosensitizer | 0.168 0.022 DBMET01828 | ||
| 0.312 | 0.017 | 0.312 | Phospholipase C inhibitor | 0.184 0.057 DBMET01828 | ||
| 0.308 | 0.027 | 0.473 | Hepatoprotectant | 0.473 0.008 DBMET01828 | DBMET01828 | |
| 0.283 | 0.004 | 0.283 | Vanilloid 1 agonist | 0.161 0.029 DBMET01828 | ||
| 0.33 | 0.052 | 0.33 | Antioxidant | 0.209 0.107 DBMET01828 | ||
| 0.294 | 0.018 | 0.294 | Protein kinase stimulant | 0.219 0.035 DBMET01828 | ||
| 0.288 | 0.02 | 0.288 | NOS3 expression enhancer | 0.188 0.046 DBMET01828 | ||
| 0.29 | 0.023 | 0.29 | Lipocortins synthesis antagonist | 0.271 0.027 DBMET01828 | ||
| 0.331 | 0.066 | 0.331 | Apoptosis antagonist | 0.293 0.09 DBMET01828 | ||
| 0.261 | 0.003 | 0.261 | Purinergic P2Y12 antagonist | |||
| 0.262 | 0.005 | 0.262 | Microtubule formation inhibitor | 0.243 0.01 DBMET01828 | ||
| 0.247 | 0.006 | 0.247 | Arachidonic acid antagonist | 0.24 0.008 DBMET01828 | ||
| 0.265 | 0.024 | 0.265 | Amylase inhibitor | 0.167 0.056 DBMET01828 | ||
| 0.287 | 0.048 | 0.318 | DNA synthesis inhibitor | 0.318 0.038 DBMET01828 | DBMET01828 | |
| 0.267 | 0.037 | 0.267 | Non-steroidal antiinflammatory agent | 0.192 0.078 DBMET01828 | ||
| 0.24 | 0.014 | 0.24 | Neurotrophic factor | 0.182 0.037 DBMET01828 | ||
| 0.24 | 0.015 | 0.24 | Antineoplastic antibiotic | 0.233 0.016 DBMET01828 | ||
| 0.231 | 0.016 | 0.231 | GABA C receptor agonist | 0.225 0.016 DBMET01828 | ||
| 0.213 | 0.004 | 0.213 | Glycine receptor agonist | 0.162 0.005 DBMET01828 | ||
| 0.215 | 0.01 | 0.339 | Mucolytic | 0.339 0.004 DBMET01828 | DBMET01828 | |
| 0.212 | 0.009 | 0.212 | TRPA1 agonist | 0.105 0.078 DBMET01828 | ||
| 0.216 | 0.014 | 0.218 | CF transmembrane conductance regulator agonist | 0.218 0.014 DBMET01828 | DBMET01828 | |
| 0.245 | 0.045 | 0.245 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.165 0.117 DBMET01828 | ||
| 0.203 | 0.01 | 0.213 | Pregnane X receptor agonist | 0.213 0.008 DBMET01828 | DBMET01828 | |
| 0.222 | 0.029 | 0.222 | Heat shock protein 90 antagonist | |||
| 0.259 | 0.072 | 0.383 | Hypoglycemic | 0.383 0.03 DBMET01828 | DBMET01828 | |
| 0.2 | 0.014 | 0.209 | Adenylate cyclase stimulant | 0.209 0.01 DBMET01828 | DBMET01828 | |
| 0.25 | 0.068 | 0.25 | Free radical scavenger | |||
| 0.263 | 0.083 | 0.263 | 5 Hydroxytryptamine release stimulant | 0.22 0.106 DBMET01828 | ||
| 0.182 | 0.003 | 0.182 | Cholesterol esterase inhibitor | 0.056 0.022 DBMET01828 | ||
| 0.236 | 0.062 | 0.255 | Peptidyltransferase inhibitor | 0.255 0.047 DBMET01828 | DBMET01828 | |
| 0.181 | 0.008 | 0.181 | Prostaglandin EP2 antagonist | 0.148 0.01 DBMET01828 | ||
| 0.184 | 0.012 | 0.184 | Opioid kappa receptor antagonist | 0.183 0.012 DBMET01828 | ||
| 0.178 | 0.008 | 0.183 | Ca2+-transporting ATPase inhibitor | 0.183 0.005 DBMET01828 | DBMET01828 | |
| 0.199 | 0.03 | 0.234 | Cell wall synthesis inhibitor | 0.234 0.019 DBMET01828 | DBMET01828 | |
| 0.17 | 0.005 | 0.241 | Glycine receptor antagonist | 0.241 0.003 DBMET01828 | DBMET01828 | |
| 0.168 | 0.004 | 0.168 | Glutamate (mGluR3) antagonist | 0.058 0.009 DBMET01828 | ||
| 0.246 | 0.082 | 0.246 | DNA damaging | 0.161 0.156 DBMET01828 | ||
| 0.24 | 0.078 | 0.25 | Tyrosine 3 hydroxylase inhibitor | 0.25 0.068 DBMET01828 | DBMET01828 | |
| 0.233 | 0.073 | 0.233 | Cyclic AMP phosphodiesterase inhibitor | 0.17 0.123 DBMET01828 | ||
| 0.164 | 0.005 | 0.164 | ATPase (Vacuolar H+) inhibitor | 0.152 0.007 DBMET01828 | ||
| 0.185 | 0.027 | 0.185 | Farnesoid X receptor antagonist | 0.169 0.035 DBMET01828 | ||
| 0.161 | 0.005 | 0.161 | Opioid kappa receptor agonist | 0.129 0.007 DBMET01828 | ||
| 0.194 | 0.039 | 0.194 | Insulin secretagoues | |||
| 0.167 | 0.013 | 0.167 | CYP2A6 inhibitor | |||
| 0.173 | 0.02 | 0.234 | GABA C receptor antagonist | 0.234 0.008 DBMET01828 | DBMET01828 | |
| 0.164 | 0.012 | 0.18 | Anabolic | 0.18 0.007 DBMET01828 | DBMET01828 | |
| 0.229 | 0.08 | 0.255 | Angiogenesis stimulant | 0.255 0.068 DBMET01828 | DBMET01828 | |
| 0.198 | 0.05 | 0.198 | Heat shock protein 90 alpha antagonist | |||
| 0.214 | 0.068 | 0.214 | Nitric-oxide synthase stimulant | 0.208 0.076 DBMET01828 | ||
| 0.162 | 0.017 | 0.162 | Triose-phosphate isomerase inhibitor | 0.141 0.023 DBMET01828 | ||
| 0.166 | 0.024 | 0.166 | UDP-glucose 4-epimerase inhibitor | 0.156 0.027 DBMET01828 | ||
| 0.151 | 0.011 | 0.151 | Interleukin 5 antagonist | 0.119 0.024 DBMET01828 | ||
| 0.145 | 0.005 | 0.145 | Prostaglandin F2 alpha antagonist | 0.128 0.005 DBMET01828 | ||
| 0.156 | 0.016 | 0.156 | Interleukin 2 antagonist | 0.107 0.071 DBMET01828 | ||
| 0.172 | 0.034 | 0.172 | Interleukin 4 antagonist | 0.134 0.066 DBMET01828 | ||
| 0.143 | 0.005 | 0.143 | TRPM8 blocker | 0.043 0.021 DBMET01828 | ||
| 0.144 | 0.007 | 0.144 | Protein 50S ribosomal subunit inhibitor | 0.123 0.009 DBMET01828 | ||
| 0.132 | 0.005 | 0.132 | Heat shock protein 90 beta antagonist | 0.054 0.051 DBMET01828 | ||
| 0.15 | 0.022 | 0.15 | Prolactin inhibitor | 0.098 0.057 DBMET01828 | ||
| 0.15 | 0.023 | 0.15 | Transcription factor STAT6 inhibitor | |||
| 0.204 | 0.078 | 0.319 | Psychostimulant | 0.319 0.038 DBMET01828 | DBMET01828 | |
| 0.131 | 0.006 | 0.131 | Purinergic P2Y antagonist | 0.04 0.036 DBMET01828 | ||
| 0.181 | 0.057 | 0.181 | Cytidine deaminase inhibitor | |||
| 0.132 | 0.009 | 0.132 | Opioid agonist | 0.053 0.037 DBMET01828 | ||
| 0.134 | 0.012 | 0.144 | mTOR complex 2 inhibitor | 0.144 0.01 DBMET01828 | DBMET01828 | |
| 0.129 | 0.009 | 0.167 | Androgen agonist | 0.167 0.006 DBMET01828 | DBMET01828 | |
| 0.136 | 0.018 | 0.136 | Lanosterol 14 alpha demethylase inhibitor | 0.132 0.02 DBMET01828 | ||
| 0.144 | 0.029 | 0.144 | Adenylate kinase inhibitor | 0.138 0.031 DBMET01828 | ||
| 0.127 | 0.013 | 0.136 | Na+ K+ transporting ATPase inhibitor | 0.136 0.009 DBMET01828 | DBMET01828 | |
| 0.127 | 0.014 | 0.127 | Bile acid receptor antagonist | 0.1 0.049 DBMET01828 | ||
| 0.187 | 0.074 | 0.194 | P-glycoprotein inhibitor | 0.194 0.068 DBMET01828 | DBMET01828 | |
| 0.133 | 0.022 | 0.155 | Phosphofructokinase-1 inhibitor | 0.155 0.017 DBMET01828 | DBMET01828 | |
| 0.131 | 0.019 | 0.143 | mTOR complex 1 inhibitor | 0.143 0.013 DBMET01828 | DBMET01828 | |
| 0.139 | 0.03 | 0.139 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.132 0.033 DBMET01828 | ||
| 0.139 | 0.029 | 0.139 | Opioid antagonist | 0.13 0.032 DBMET01828 | ||
| 0.121 | 0.015 | 0.121 | Purinergic P2 antagonist | |||
| 0.124 | 0.021 | 0.124 | Analgesic, opioid | 0.102 0.03 DBMET01828 | ||
| 0.217 | 0.114 | 0.262 | Transcription factor STAT3 inhibitor | 0.262 0.075 DBMET01828 | DBMET01828 | |
| 0.123 | 0.023 | 0.123 | Inducible nitric-oxide synthase inhibitor | |||
| 0.107 | 0.008 | 0.114 | Glutamate (mGluR6) antagonist | 0.114 0.006 DBMET01828 | DBMET01828 | |
| 0.132 | 0.033 | 0.132 | HIV-1 integrase (Overall Integration) inhibitor | 0.094 0.061 DBMET01828 | ||
| 0.125 | 0.026 | 0.125 | NADH dehydrogenase inhibitor | 0.12 0.028 DBMET01828 | ||
| 0.1 | 0.002 | 0.1 | Glutamate (mGluR3) agonist | 0.054 0.004 DBMET01828 | ||
| 0.146 | 0.051 | 0.195 | DNA polymerase I inhibitor | 0.195 0.03 DBMET01828 | DBMET01828 | |
| 0.125 | 0.031 | 0.145 | Androgen antagonist | 0.145 0.024 DBMET01828 | DBMET01828 | |
| 0.097 | 0.004 | 0.097 | ATP citrate lysase inhibitor | 0.048 0.008 DBMET01828 | ||
| 0.117 | 0.028 | 0.117 | Ornithine decarboxylase inhibitor | 0.098 0.047 DBMET01828 | ||
| 0.106 | 0.017 | 0.106 | Alcohol oxidase inhibitor | 0.101 0.018 DBMET01828 | ||
| 0.107 | 0.019 | 0.123 | Carbamoyl phosphate synthetase inhibitor | 0.123 0.015 DBMET01828 | DBMET01828 | |
| 0.09 | 0.004 | 0.09 | Parathyroid hormone antagonist | 0.055 0.016 DBMET01828 | ||
| 0.134 | 0.049 | 0.134 | Cystathionine beta-synthase inhibitor | 0.123 0.056 DBMET01828 | ||
| 0.168 | 0.083 | 0.168 | Succinate dehydrogenase inhibitor | 0.166 0.086 DBMET01828 | ||
| 0.217 | 0.133 | 0.217 | Hypoxia-inducible factor 1 alpha inhibitor | 0.21 0.14 DBMET01828 | ||
| 0.094 | 0.01 | 0.107 | 5-Alpha-reductase inhibitor | 0.107 0.009 DBMET01828 | DBMET01828 | |
| 0.276 | 0.193 | 0.284 | 5 Hydroxytryptamine release inhibitor | 0.284 0.184 DBMET01828 | DBMET01828 | |
| 0.126 | 0.044 | 0.126 | Estrogen antagonist | 0.105 0.086 DBMET01828 | ||
| 0.143 | 0.065 | 0.143 | Calcium channel blocker | |||
| 0.082 | 0.004 | 0.082 | Prostaglandin D2 agonist | 0.078 0.004 DBMET01828 | ||
| 0.104 | 0.026 | 0.104 | Interferon agonist | 0.1 0.028 DBMET01828 | ||
| 0.102 | 0.026 | 0.102 | Estrogen receptor alpha antagonist | 0.079 0.05 DBMET01828 | ||
| 0.085 | 0.011 | 0.085 | Lipocortins synthesis agonist | 0.084 0.011 DBMET01828 | ||
| 0.078 | 0.004 | 0.078 | HMG CoA reductase inhibitor | 0.053 0.006 DBMET01828 | ||
| 0.094 | 0.019 | 0.094 | MAP kinase kinase 7 inhibitor | 0.094 0.019 DBMET01828 | ||
| 0.099 | 0.025 | 0.099 | Estrogen-related receptor beta agonist | 0.081 0.065 DBMET01828 | ||
| 0.091 | 0.017 | 0.091 | Interferon inducer | 0.087 0.019 DBMET01828 | ||
| 0.131 | 0.058 | 0.131 | Adenylate cyclase inhibitor | 0.105 0.08 DBMET01828 | ||
| 0.081 | 0.008 | 0.081 | Ryanodine receptor antagonist | 0.063 0.029 DBMET01828 | ||
| 0.079 | 0.008 | 0.079 | Nociceptin (N/OFQ) receptor antagonist | |||
| 0.088 | 0.019 | 0.088 | Acyl-CoA dehydrogenase inhibitor | 0.083 0.021 DBMET01828 | ||
| 0.11 | 0.042 | 0.11 | Glutamate (mGluR7) agonist | |||
| 0.089 | 0.022 | 0.104 | Argininosuccinate synthase inhibitor | 0.104 0.018 DBMET01828 | DBMET01828 | |
| 0.182 | 0.115 | 0.197 | Aldehyde oxidase inhibitor | 0.197 0.106 DBMET01828 | DBMET01828 | |
| 0.07 | 0.004 | 0.07 | Prostacyclin agonist | 0.065 0.004 DBMET01828 | ||
| 0.075 | 0.009 | 0.098 | Pregnane X receptor antagonist | 0.098 0.004 DBMET01828 | DBMET01828 | |
| 0.089 | 0.024 | 0.089 | Aromatase inhibitor | |||
| 0.09 | 0.026 | 0.09 | Vanilloid 4 agonist | 0.088 0.028 DBMET01828 | ||
| 0.074 | 0.011 | 0.079 | Glucose-6-phosphate isomerase inhibitor | 0.079 0.009 DBMET01828 | DBMET01828 | |
| 0.111 | 0.048 | 0.111 | Creatine kinase inhibitor | 0.103 0.056 DBMET01828 | ||
| 0.066 | 0.004 | 0.066 | Vitamin D receptor antagonist | 0.033 0.006 DBMET01828 | ||
| 0.19 | 0.128 | 0.19 | Superoxide dismutase inhibitor | |||
| 0.139 | 0.078 | 0.139 | Heat shock protein 70 antagonist | 0.131 0.116 DBMET01828 | ||
| 0.068 | 0.007 | 0.068 | Farnesoid X receptor agonist | 0.054 0.013 DBMET01828 | ||
| 0.094 | 0.034 | 0.106 | Glutamate dehydrogenase inhibitor | 0.106 0.028 DBMET01828 | DBMET01828 | |
| 0.063 | 0.005 | 0.063 | Tubulin agonist | 0.062 0.005 DBMET01828 | ||
| 0.073 | 0.015 | 0.079 | Alpha-mannosidase inhibitor | 0.079 0.012 DBMET01828 | DBMET01828 | |
| 0.061 | 0.003 | 0.067 | Prostaglandin F2 alpha agonist | 0.067 0.003 DBMET01828 | DBMET01828 | |
| 0.075 | 0.018 | 0.128 | Glucosylceramidase inhibitor | 0.128 0.005 DBMET01828 | DBMET01828 | |
| 0.229 | 0.173 | 0.229 | Histamine release inhibitor | |||
| 0.077 | 0.022 | 0.077 | Acetyl-CoA transferase inhibitor | |||
| 0.065 | 0.009 | 0.065 | Microtubule stabilization | 0.06 0.014 DBMET01828 | ||
| 0.077 | 0.022 | 0.077 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.073 0.024 DBMET01828 | ||
| 0.06 | 0.007 | 0.064 | Kainate receptor agonist | 0.064 0.005 DBMET01828 | DBMET01828 | |
| 0.086 | 0.034 | 0.086 | Leukotriene synthesis inhibitor | 0.076 0.04 DBMET01828 | ||
| 0.06 | 0.007 | 0.06 | Delayed rectifier potassium channel blocker | 0.043 0.018 DBMET01828 | ||
| 0.057 | 0.005 | 0.057 | Cholesterol ester transfer protein antagonist | 0.049 0.007 DBMET01828 | ||
| 0.126 | 0.076 | 0.126 | NADPH oxidase inhibitor | 0.108 0.099 DBMET01828 | ||
| 0.068 | 0.02 | 0.068 | Acetyl-CoA transferase 2 inhibitor | 0.06 0.032 DBMET01828 | ||
| 0.053 | 0.005 | 0.053 | Nociceptin (N/OFQ) receptor agonist | |||
| 0.104 | 0.057 | 0.104 | Estrogen receptor beta antagonist | |||
| 0.114 | 0.067 | 0.114 | Protein-tyrosine phosphatase 1B inhibitor | |||
| 0.075 | 0.029 | 0.075 | Biliverdin reductase inhibitor | 0.072 0.03 DBMET01828 | ||
| 0.061 | 0.014 | 0.061 | Purinergic P2X4 antagonist | |||
| 0.049 | 0.004 | 0.049 | Purinergic P2Y15 antagonist | 0.044 0.005 DBMET01828 | ||
| 0.066 | 0.021 | 0.066 | Opioid mu receptor agonist | |||
| 0.063 | 0.019 | 0.063 | HCV NS3/NS4A protease inhibitor | 0.048 0.037 DBMET01828 | ||
| 0.053 | 0.01 | 0.053 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.052 0.01 DBMET01828 | ||
| 0.105 | 0.062 | 0.105 | Toll-Like receptor 4 antagonist | 0.093 0.082 DBMET01828 | ||
| 0.094 | 0.052 | 0.094 | Glutamate release inhibitor | |||
| 0.044 | 0.004 | 0.056 | Hedgehog signaling activator | 0.056 0.003 DBMET01828 | DBMET01828 | |
| 0.049 | 0.009 | 0.049 | Vanilloid 3 antagonist | 0.037 0.031 DBMET01828 | ||
| 0.086 | 0.046 | 0.086 | CC chemokine 5 receptor agonist | |||
| 0.101 | 0.063 | 0.118 | Bronchodilator | 0.118 0.046 DBMET01828 | DBMET01828 | |
| 0.079 | 0.04 | 0.079 | Opioid mu receptor antagonist | 0.068 0.047 DBMET01828 | ||
| 0.057 | 0.019 | 0.062 | Mannosidase inhibitor | 0.062 0.015 DBMET01828 | DBMET01828 | |
| 0.052 | 0.014 | 0.052 | Membrane dipeptidase inhibitor | 0.05 0.016 DBMET01828 | ||
| 0.063 | 0.025 | 0.063 | Dihydroorotate oxidase inhibitor | 0.051 0.048 DBMET01828 | ||
| 0.111 | 0.074 | 0.111 | Proteasome inhibitor | |||
| 0.062 | 0.024 | 0.069 | Aconitate hydratase inhibitor | 0.069 0.019 DBMET01828 | DBMET01828 | |
| 0.079 | 0.043 | 0.079 | Aminopeptidase I inhibitor | 0.078 0.044 DBMET01828 | ||
| 0.046 | 0.009 | 0.073 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.073 0.005 DBMET01828 | DBMET01828 | |
| 0.053 | 0.017 | 0.053 | Thymidine kinase inhibitor | 0.053 0.017 DBMET01828 | ||
| 0.068 | 0.032 | 0.068 | Calcium channel P-type blocker | |||
| 0.042 | 0.006 | 0.047 | Sodium/glucose cotransporter inhibitor | 0.047 0.005 DBMET01828 | DBMET01828 | |
| 0.058 | 0.022 | 0.058 | Squalene epoxidase inhibitor | 0.055 0.027 DBMET01828 | ||
| 0.04 | 0.004 | 0.04 | Vanilloid 2 agonist | 0.037 0.005 DBMET01828 | ||
| 0.053 | 0.018 | 0.053 | Guanylate cyclase inhibitor | 0.051 0.02 DBMET01828 | ||
| 0.106 | 0.072 | 0.106 | Monophenol monooxygenase inhibitor | |||
| 0.045 | 0.011 | 0.045 | Prostaglandin agonist | 0.043 0.012 DBMET01828 | ||
| 0.04 | 0.007 | 0.04 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.019 0.014 DBMET01828 | ||
| 0.081 | 0.047 | 0.081 | Keratolytic | 0.07 0.065 DBMET01828 | ||
| 0.183 | 0.15 | 0.183 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.055 | 0.022 | 0.055 | Adenylate cyclase 1 inhibitor | 0.055 0.021 DBMET01828 | ||
| 0.102 | 0.069 | 0.102 | Ferrochelatase inhibitor | 0.096 0.075 DBMET01828 | ||
| 0.05 | 0.018 | 0.05 | Retinoid X receptor agonist | |||
| 0.048 | 0.017 | 0.048 | Glutamate (mGluR group II) antagonist | 0.038 0.026 DBMET01828 | ||
| 0.037 | 0.006 | 0.037 | Toll-Like receptor 4 agonist | |||
| 0.032 | 0.002 | 0.032 | Calcineurin inhibitor | 0.023 0.003 DBMET01828 | ||
| 0.129 | 0.101 | 0.129 | Anticoagulant | |||
| 0.038 | 0.009 | 0.038 | LFA antagonist | 0.036 0.01 DBMET01828 | ||
| 0.042 | 0.016 | 0.042 | RNA-directed RNA polymerase stimulant | 0.039 0.017 DBMET01828 | ||
| 0.029 | 0.004 | 0.029 | Nicotinic acid receptor 1 antagonist | |||
| 0.042 | 0.019 | 0.042 | Glutamate (mGluR8) agonist | 0.042 0.02 DBMET01828 | ||
| 0.034 | 0.01 | 0.039 | Sodium/glucose cotransporter 2 inhibitor | 0.039 0.009 DBMET01828 | DBMET01828 | |
| 0.034 | 0.011 | 0.034 | Prostaglandin EP2 agonist | 0.032 0.011 DBMET01828 | ||
| 0.192 | 0.169 | 0.192 | Insulysin inhibitor | |||
| 0.093 | 0.07 | 0.093 | Aminopeptidase B inhibitor | 0.088 0.074 DBMET01828 | ||
| 0.213 | 0.192 | 0.213 | GABA C receptor rho-3 antagonist | |||
| 0.037 | 0.016 | 0.037 | Prostaglandin EP3 antagonist | |||
| 0.025 | 0.004 | 0.025 | Thromboxane A2 agonist | 0.024 0.004 DBMET01828 | ||
| 0.025 | 0.004 | 0.037 | Telomerase stimulant | 0.037 0.002 DBMET01828 | DBMET01828 | |
| 0.057 | 0.036 | 0.057 | Sphingosine kinase 2 inhibitor | |||
| 0.061 | 0.042 | 0.062 | Purinergic P2X1 antagonist | 0.062 0.041 DBMET01828 | DBMET01828 | |
| 0.039 | 0.019 | 0.047 | Fumarate hydratase inhibitor | 0.047 0.015 DBMET01828 | DBMET01828 | |
| 0.103 | 0.085 | 0.103 | Alkylator | |||
| 0.059 | 0.041 | 0.059 | Sphingosine kinase inhibitor | |||
| 0.03 | 0.013 | 0.03 | Nicotinic acid receptor 2 antagonist | 0.026 0.019 DBMET01828 | ||
| 0.026 | 0.009 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.022 0.018 DBMET01828 | ||
| 0.022 | 0.005 | 0.023 | Vitamin D receptor agonist | 0.023 0.005 DBMET01828 | DBMET01828 | |
| 0.033 | 0.016 | 0.033 | Glutamate (mGluR2) antagonist | 0.027 0.025 DBMET01828 | ||
| 0.03 | 0.014 | 0.03 | 1,3-Beta-glucan synthase inhibitor | |||
| 0.087 | 0.071 | 0.121 | ABCA1 expression enhancer | 0.121 0.03 DBMET01828 | DBMET01828 | |
| 0.071 | 0.055 | 0.071 | CDC25A inhibitor | |||
| 0.091 | 0.076 | 0.091 | Nitric-oxide synthase inhibitor | |||
| 0.019 | 0.004 | 0.019 | Thromboxane agonist | 0.014 0.005 DBMET01828 | ||
| 0.023 | 0.009 | 0.023 | Progesterone receptor B antagonist | |||
| 0.043 | 0.029 | 0.043 | Oxytocin agonist | |||
| 0.043 | 0.029 | 0.043 | Histamine H2 receptor agonist | |||
| 0.02 | 0.007 | 0.02 | Antibiotic Macrolide-like | 0.018 0.008 DBMET01828 | ||
| 0.028 | 0.015 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 DBMET01828 | DBMET01828 | |
| 0.022 | 0.011 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.065 | 0.054 | 0.065 | MDM2 inhibitor | |||
| 0.02 | 0.009 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.01 DBMET01828 | ||
| 0.033 | 0.023 | 0.033 | Carboxypeptidase B inhibitor | |||
| 0.02 | 0.011 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.01 DBMET01828 | ||
| 0.111 | 0.103 | 0.111 | Lipid peroxidase inhibitor | |||
| 0.015 | 0.006 | 0.015 | Integrin beta2 antagonist | |||
| 0.017 | 0.009 | 0.017 | NMDA receptor phencyclidine site antagonist | |||
| 0.024 | 0.016 | 0.024 | Prostaglandin E2 agonist | 0.022 0.018 DBMET01828 | ||
| 0.048 | 0.041 | 0.048 | Ornithine carbamoyltransferase inhibitor | 0.047 0.042 DBMET01828 | ||
| 0.267 | 0.26 | 0.267 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.018 | 0.011 | 0.018 | Ileal bile acid transport inhibitor | |||
| 0.05 | 0.044 | 0.05 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.045 | 0.039 | 0.045 | Estrogen agonist | 0.044 0.039 DBMET01828 | ||
| 0.043 | 0.037 | 0.043 | Potassium channel Kv1.3 blocker | |||
| 0.041 | 0.035 | 0.041 | Geranyltranstransferase inhibitor | |||
| 0.019 | 0.014 | 0.019 | 5-Alpha-reductase 2 inhibitor | |||
| 0.02 | 0.015 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.064 | 0.059 | 0.064 | Exportin-1 inhibitor | |||
| 0.135 | 0.13 | 0.135 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.021 | 0.015 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.02 0.017 DBMET01828 | ||
| 0.039 | 0.034 | 0.039 | Sphingosine kinase 1 inhibitor | |||
| 0.057 | 0.053 | 0.057 | Nitric oxide donor | |||
| 0.056 | 0.053 | 0.061 | Selectin antagonist | 0.061 0.049 DBMET01828 | DBMET01828 | |
| 0.007 | 0.003 | 0.008 | Transcortin receptor antagonist | 0.008 0.003 DBMET01828 | DBMET01828 | |
| 0.022 | 0.018 | 0.022 | ICAM 1 antagonist | |||
| 0.012 | 0.009 | 0.012 | Glutamate (mGluR6) agonist | 0.011 0.009 DBMET01828 | ||
| 0.07 | 0.067 | 0.07 | GABA B receptor agonist | |||
| 0.031 | 0.028 | 0.031 | ADAM10 endopeptidase inhibitor | |||
| 0.033 | 0.03 | 0.035 | Antibiotic Aminoglycoside-like | 0.035 0.026 DBMET01828 | DBMET01828 | |
| 0.058 | 0.055 | 0.058 | Phosphodiesterase 1C inhibitor | |||
| 0.02 | 0.017 | 0.021 | Corticosteroid-like | 0.021 0.015 DBMET01828 | DBMET01828 | |
| 0.057 | 0.054 | 0.057 | Purinergic P2X2 antagonist | |||
| 0.12 | 0.118 | 0.224 | Hexokinase inhibitor | 0.224 0.024 DBMET01828 | DBMET01828 | |
| 0.066 | 0.064 | 0.066 | Phospholipase D inhibitor | |||
| 0.004 | 0.003 | 0.004 | Vitamin D-like | |||
| 0.045 | 0.044 | 0.045 | Cytokine production stimulant | |||
| 0.074 | 0.074 | 0.13 | Antineoplastic alkaloid | 0.13 0.034 DBMET01828 | DBMET01828 | |
| 0.014 | 0.016 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.011 DBMET01828 | DBMET01828 | |
| 0.088 | 0.091 | 0.093 | Hedgehog signaling inhibitor | 0.093 0.078 DBMET01828 | DBMET01828 | |
| 0.027 | 0.033 | 0.037 | Progesterone antagonist | 0.037 0.024 DBMET01828 | DBMET01828 | |
| 0.033 | 0.039 | 0.04 | GABA uptake inhibitor | 0.04 0.027 DBMET01828 | DBMET01828 | |
| 0.017 | 0.032 | 0.028 | Estrogen receptor beta agonist | 0.028 0.024 DBMET01828 | DBMET01828 | |
| 0.005 | 0.023 | 0.013 | Glucocorticoid agonist | 0.013 0.009 DBMET01828 | DBMET01828 | |
| 0.083 | 0.101 | 0.106 | AMP-activated protein kinase stimulant | 0.106 0.063 DBMET01828 | DBMET01828 | |
| 0.064 | 0.084 | 0.081 | Carbonic anhydrase VI inhibitor | 0.081 0.056 DBMET01828 | DBMET01828 | |
| 0.042 | 0.063 | 0.054 | Opioid delta receptor antagonist | 0.054 0.051 DBMET01828 | DBMET01828 | |
| 0.023 | 0.043 | 0.032 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.032 0.022 DBMET01828 | DBMET01828 | |
| 0.037 | 0.063 | 0.05 | Diacylglycerol O-acyltransferase inhibitor | 0.05 0.037 DBMET01828 | DBMET01828 | |
| 0.073 | 0.105 | 0.087 | Gastric antisecretory | 0.087 0.083 DBMET01828 | DBMET01828 | |
| 0.068 | 0.106 | 0.102 | Transcription factor NF kappa B stimulant | 0.102 0.037 DBMET01828 | DBMET01828 | |
| 0.1 | 0.14 | 0.141 | Acetylcholine M1 receptor antagonist | 0.141 0.083 DBMET01828 | DBMET01828 | |
| 0.014 | 0.055 | 0.033 | Glucocorticoid antagonist | 0.033 0.022 DBMET01828 | DBMET01828 | |
| 0.023 | 0.072 | 0.125 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.125 0.008 DBMET01828 | DBMET01828 | |
| 0.177 | 0.237 | 0.417 | Antiobesity | 0.417 0.059 DBMET01828 | DBMET01828 | |
| 0.056 | 0.135 | 0.08 | Pim-3 kinase inhibitor | 0.08 0.076 DBMET01828 | DBMET01828 | |
| 0.067 | 0.164 | 0.118 | Bone formation stimulant | 0.118 0.087 DBMET01828 | DBMET01828 | |
| 0.015 | 0.182 | 0.072 | Liver X receptor agonist | 0.072 0.013 DBMET01828 | DBMET01828 | |
| 0.028 | 0.218 | 0.107 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.107 0.04 DBMET01828 | DBMET01828 | |
| 0.067 | 0.345 | 0.134 | Tumour necrosis factor antagonist | 0.134 0.121 DBMET01828 | DBMET01828 | |
| 0.057 | 0.382 | 0.198 | Tumour necrosis factor alpha release inhibitor | 0.198 0.11 DBMET01828 | DBMET01828 | |
| 0.007 | 0.371 | 0.031 | Liver X receptor alpha antagonist | 0.031 0.017 DBMET01828 | DBMET01828 | |
| 0.076 | 0.459 | 0.263 | Toll-Like receptor agonist | 0.263 0.137 DBMET01828 | DBMET01828 | |
| 0.006 | 0.391 | 0.038 | Liver X receptor antagonist | 0.038 0.015 DBMET01828 | DBMET01828 | |
| 0.063 | 0.509 | 0.267 | Toll-Like receptor 7 agonist | 0.267 0.133 DBMET01828 | DBMET01828 | |
| 0.016 | 0.818 | 0.182 | MAP3K9 inhibitor | 0.182 0.025 DBMET01828 | DBMET01828 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |